Modern trends in the complex therapy of patients with erectile dysfunction and lower urinary tract symptoms on a background of benign prostatic hyperplasia

##plugins.themes.bootstrap3.article.sidebar##

PDF (Русский)
DOI: https://doi.org/10.30841/2307-5090.1(56).2016.95425
Keywords:
benign prostatic hyperplasia, erectile dysfunction, lower urinary tract symptoms, Pravenor® Forte,

##plugins.themes.bootstrap3.article.main##

І. І. Горпинченко
ГУ «Институт урологии НАМН Украины», г. Киев, Ukraine
А. М. Ситенко
Украинский институт сексологии и андрологии, Ukraine

Abstract

An open study of the efficacy and tolerability Pravenor® Forte in 30 patients with erectile dysfunction and lower urinary tract symptoms (LUTS) due to BPH was performed. Treatment regimen: 2 capsules per os Pravenor® Forte 1 times a day for 30 days. It was established that Pravenor® Forte statistically and clinically significantly improves main efficacy indicators (MIEF-5, IPSS, QoL) and the hardness of erection, cavernous hemodynamic performance, Qmax. Furthermore it increases the concentration of total testosterone and reduces the concentration of estradiol in the blood serum. For significant reduction Vprostate, PVR and total PSA it is recommended a longer-term administration of Pravenor® Forte (more than 1 month) in patients with LUTS and ED BPH. Pravenor® Forte can be recommended in complex treatment of patients with LUTS and ED BPH.

##plugins.themes.bootstrap3.article.details##

How to Cite
Горпинченко, І. І., & Ситенко, А. М. (2016). Modern trends in the complex therapy of patients with erectile dysfunction and lower urinary tract symptoms on a background of benign prostatic hyperplasia. Health of Man, (1(56), 114–120. https://doi.org/10.30841/2307-5090.1(56).2016.95425
Issue
No. 1(56) (2016)
Section
Urology
Copyright (c) 2020 І. І. Горпинченко, А. М. Ситенко

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.

Author Biographies

І. І. Горпинченко, ГУ «Институт урологии НАМН Украины», г. Киев

I. Gorpynchenko

А. М. Ситенко, Украинский институт сексологии и андрологии

A. Sytenko

References

Gorpinchenko I.I. Jerektil'naja disfunkcija: diagnostika i sovremennye metody lechenija // Zdorov'e muzhchiny. – 2002. – № 1. – S. 9–11.

Gorpinchenko I.I., Miroshnikov Ja.O. Jerektil'naja disfunkcija. – L.: Medicina svitu, 2003.

Gorpinchenko I.I. Primenenie Larginina v lechenii jerektil'noj disfunkcii // Zdorov'e muzhchiny. – 2013. – № 1 (44). – S. 39–40.

Neychev V., Mitev V. Pro-sexual and androgen enhancing effects of Tribulus terrestris L.: Fact or Fiction. J Ethnopharmacol. 2016 Feb 17; 179: 345–55.

Safarinejad M.R. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study // J. Herb. Pharmacother // 2005;5(4):1–11.

Wu Y.N., Liao C.H., Chen K.C., Liu S.P., Chiang H.S. Effect of Ginkgo biloba Extract (EGb-761) on Recovery of Erectile Dysfunction in Bilateral Cavernous Nerve Injury Rat Model. Urology. 2015 May; 85(5): 1214. e7–15.

Ajayi A.A., Newaz M., Hercule H., Saleh M., Bode C.O., Oyekan A.O. Endothelin-like action of Pausinystalia yohimbe aqueous extract on vascular and renal regional hemodynamics in Sprague Dawley rats //Methods Find Exp Clin Pharmacol. 2003 Dec;25(10):817–22.

Safarinejad M.R. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study//.J Herb Pharmacother. 2005;5(4):1–11.

Moradi H.R., Erfani Majd N., Esmaeilzadeh S., Fatemi Tabatabaei S.R. The histological and histometrical effects of Urtica dioica extract on rat’s prostate hyperplasia.Vet Res Forum.// 2015 6(1):23–9.

Latil A., Pétrissans M.T., Rouquet J., Robert G., de la Taille A. Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.Prostate. 2015 Dec;75(16):1857–67.

Belcaro G1, Dugall M, Luzzi R, Ledda A, Pellegrini L, Hosoi M, Errichi BM, Francis S, Cornelli U. Supplementary management of benign prostatic hypertrophy with Prostaquil. An 8-week registry.// Minerva Gastroenterol Dietol. 2015 Oct 22. [Epub ahead of print].

Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms – long-term follow-up of a placebo-controlled, doubleblind, multicenter trial./Nikolai Lopatkin, Andrey Silkov, Sandra Schlafke, Petra Funk, Alexander Medvedev, Udo Engelmann//International Urology and Nephrology. December 2007, Volume 39, Issue 4, pp 1137–1146/